326 related articles for article (PubMed ID: 25933416)
1. Ethanolic Echinacea purpurea Extracts Contain a Mixture of Cytokine-Suppressive and Cytokine-Inducing Compounds, Including Some That Originate from Endophytic Bacteria.
Todd DA; Gulledge TV; Britton ER; Oberhofer M; Leyte-Lugo M; Moody AN; Shymanovich T; Grubbs LF; Juzumaite M; Graf TN; Oberlies NH; Faeth SH; Laster SM; Cech NB
PLoS One; 2015; 10(5):e0124276. PubMed ID: 25933416
[TBL] [Abstract][Full Text] [Related]
2. Mast cell degranulation and calcium influx are inhibited by an Echinacea purpurea extract and the alkylamide dodeca-2E,4E-dienoic acid isobutylamide.
Gulledge TV; Collette NM; Mackey E; Johnstone SE; Moazami Y; Todd DA; Moeser AJ; Pierce JG; Cech NB; Laster SM
J Ethnopharmacol; 2018 Feb; 212():166-174. PubMed ID: 29042288
[TBL] [Abstract][Full Text] [Related]
3. Echinacea and its alkylamides: effects on the influenza A-induced secretion of cytokines, chemokines, and PGE₂ from RAW 264.7 macrophage-like cells.
Cech NB; Kandhi V; Davis JM; Hamilton A; Eads D; Laster SM
Int Immunopharmacol; 2010 Oct; 10(10):1268-78. PubMed ID: 20674883
[TBL] [Abstract][Full Text] [Related]
4. Echinacea alkylamides inhibit interleukin-2 production by Jurkat T cells.
Sasagawa M; Cech NB; Gray DE; Elmer GW; Wenner CA
Int Immunopharmacol; 2006 Jul; 6(7):1214-21. PubMed ID: 16714226
[TBL] [Abstract][Full Text] [Related]
5. Secondary Metabolites from Fungal Endophytes of
Kaur A; Oberhofer M; Juzumaite M; Raja HA; Gulledge TV; Kao D; Faeth SH; Laster SM; Oberlies NH; Cech NB
Nat Prod Commun; 2016 Jan; 11(8):1143-1146. PubMed ID: 28479944
[TBL] [Abstract][Full Text] [Related]
6. Alkylamides of Echinacea purpurea stimulate alveolar macrophage function in normal rats.
Goel V; Chang C; Slama JV; Barton R; Bauer R; Gahler R; Basu TK
Int Immunopharmacol; 2002 Feb; 2(2-3):381-7. PubMed ID: 11811940
[TBL] [Abstract][Full Text] [Related]
7. Comparison of alkylamide yield in ethanolic extracts prepared from fresh versus dry Echinacea purpurea utilizing HPLC-ESI-MS.
Spelman K; Wetschler MH; Cech NB
J Pharm Biomed Anal; 2009 Jul; 49(5):1141-9. PubMed ID: 19321283
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic profiling of liquid Echinacea medicinal products with in vitro inhibitory effects on cytochrome P450 3A4 (CYP3A4).
Modarai M; Yang M; Suter A; Kortenkamp A; Heinrich M
Planta Med; 2010 Mar; 76(4):378-85. PubMed ID: 19790031
[TBL] [Abstract][Full Text] [Related]
9. Effects of chemically characterized fractions from aerial parts of Echinacea purpurea and E. angustifolia on myelopoiesis in rats.
Ramasahayam S; Baraka HN; Abdel Bar FM; Abuasal BS; Widrlechner MP; Sayed KA; Meyer SA
Planta Med; 2011 Nov; 77(17):1883-9. PubMed ID: 21870322
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antioxidative effects of alkamides, caffeic acid derivatives, and polysaccharide fractions from Echinacea purpurea on in vitro oxidation of human low-density lipoproteins.
Dalby-Brown L; Barsett H; Landbo AK; Meyer AS; Mølgaard P
J Agric Food Chem; 2005 Nov; 53(24):9413-23. PubMed ID: 16302756
[TBL] [Abstract][Full Text] [Related]
11. Cytokine production by non-adherent mouse splenocyte cultures to Echinacea extracts.
Hwang SA; Dasgupta A; Actor JK
Clin Chim Acta; 2004 May; 343(1-2):161-6. PubMed ID: 15115689
[TBL] [Abstract][Full Text] [Related]
12.
Cadiz MP; Schara MR; Kemp BH; Gibbons Johnson RM
J Med Food; 2019 Nov; 22(11):1146-1150. PubMed ID: 31274384
[No Abstract] [Full Text] [Related]
13. Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts.
Chicca A; Raduner S; Pellati F; Strompen T; Altmann KH; Schoop R; Gertsch J
Int Immunopharmacol; 2009 Jul; 9(7-8):850-8. PubMed ID: 19303464
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of a series of fatty acid amides from Echinacea.
Moazami Y; Gulledge TV; Laster SM; Pierce JG
Bioorg Med Chem Lett; 2015 Aug; 25(16):3091-4. PubMed ID: 26105195
[TBL] [Abstract][Full Text] [Related]
15. Modulation of macrophage immune responses by Echinacea.
Stevenson LM; Matthias A; Banbury L; Penman KG; Bone KM; Leach DL; Lehmann RP
Molecules; 2005 Oct; 10(10):1279-85. PubMed ID: 18007520
[TBL] [Abstract][Full Text] [Related]
16. Endogenous levels of Echinacea alkylamides and ketones are important contributors to the inhibition of prostaglandin E2 and nitric oxide production in cultured macrophages.
LaLone CA; Rizshsky L; Hammer KD; Wu L; Solco AK; Yum M; Nikolau BJ; Wurtele ES; Murphy PA; Kim M; Birt DF
J Agric Food Chem; 2009 Oct; 57(19):8820-30. PubMed ID: 19807154
[TBL] [Abstract][Full Text] [Related]
17. Liver enzyme-mediated oxidation of Echinacea purpurea alkylamides: production of novel metabolites and changes in immunomodulatory activity.
Cech NB; Tutor K; Doty BA; Spelman K; Sasagawa M; Raner GM; Wenner CA
Planta Med; 2006 Dec; 72(15):1372-7. PubMed ID: 17054047
[TBL] [Abstract][Full Text] [Related]
18. Echinacea extracts modulate the pattern of chemokine and cytokine secretion in rhinovirus-infected and uninfected epithelial cells.
Sharma M; Arnason JT; Burt A; Hudson JB
Phytother Res; 2006 Feb; 20(2):147-52. PubMed ID: 16444669
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content.
Modarai M; Gertsch J; Suter A; Heinrich M; Kortenkamp A
J Pharm Pharmacol; 2007 Apr; 59(4):567-73. PubMed ID: 17430641
[TBL] [Abstract][Full Text] [Related]
20. Echinacea purpurea root extract inhibits TNF release in response to Pam3Csk4 in a phosphatidylinositol-3-kinase dependent manner.
Fast DJ; Balles JA; Scholten JD; Mulder T; Rana J
Cell Immunol; 2015 Oct; 297(2):94-9. PubMed ID: 26190752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
